Month: April 2024

Original Article

Dupilumab in patients with atopic dermatitis: assessing treatment response, clinical features and potential biomarkers in real-life

/ by edra | Leave a Comment

Background. The clinical and pathophysiological heterogeneity of atopic dermatitis (AD) endophenotypes is associated with wide diversity in response to therapy. The aim of this study was to evaluate the response to dupilumab in a group of AD patients and identify clinical/immunological features associated with different patterns of response.  Methods. A retrospective observational study was performed, including 30 adults […]

Read more »

Letter to the Editor

Selective Immunoglobulin M Deficiency: an underestimated immunodeficiency

/ by almaware | Leave a Comment

Read more »

To top